Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PropoSpinECV
2024-510701-29-00Phase 4Authorised
- Sponsor
- Fundación para la Formación e Investigación Sanitaria
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in breech presentation comparing Propofol sedation for ECV with Spinal bupivacaine + fentanyl analgesia for ECV (2 arms). Primary endpoint: ECV outcome. Planned start May 2024; status: authorised.
02
Drugs
propofolbupivacaine
03
Conditions
breech presentation
Beyond the preview
Go deeper on 2024-510701-29-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-510701-29-00.